Compositions and methods for treating CDK4/6-mediated cancer
Abstract:
Methods for designing heterobifunctional small molecules which selectively degrade/disrupt CDK4/6 and compositions and methods of using such degraders/disruptors to treat CDK4/6-mediated cancer are provided.
Public/Granted literature
Information query
Patent Agency Ranking
0/0